These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 21673183)
21. Protein delivery in intermittent and continuous enteral nutrition with a protein-rich formula in critically ill patients-a protocol for the prospective randomized controlled proof-of-concept Protein Bolus Nutrition (Pro BoNo) study. Reinhold S; Yeginsoy D; Hollinger A; Todorov A; Tintignac L; Sinnreich M; Kiss C; Gebhard CE; Kovács B; Gysi B; Imwinkelried L; Siegemund M Trials; 2020 Aug; 21(1):740. PubMed ID: 32843075 [TBL] [Abstract][Full Text] [Related]
22. Neonatal Morbidity Count Is Associated With a Reduced Likelihood of Achieving Recommendations for Protein, Lipid, and Energy in Very Low Birth Weight Infants: A Prospective Cohort Study. Ng DVY; Unger S; Asbury M; Kiss A; Bishara R; Bando N; Tomlinson C; Gibbins S; O'Connor DL; JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):623-632. PubMed ID: 28537798 [TBL] [Abstract][Full Text] [Related]
23. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. Weber M; Grote V; Closa-Monasterolo R; Escribano J; Langhendries JP; Dain E; Giovannini M; Verduci E; Gruszfeld D; Socha P; Koletzko B; Am J Clin Nutr; 2014 May; 99(5):1041-51. PubMed ID: 24622805 [TBL] [Abstract][Full Text] [Related]
24. Prospective randomized trial to assess caloric and protein needs of critically Ill, anuric, ventilated patients requiring continuous renal replacement therapy. Scheinkestel CD; Kar L; Marshall K; Bailey M; Davies A; Nyulasi I; Tuxen DV Nutrition; 2003; 19(11-12):909-16. PubMed ID: 14624937 [TBL] [Abstract][Full Text] [Related]
25. Early enteral administration of immunonutrition in critically ill children: results of a blinded randomized controlled clinical trial. Briassoulis G; Filippou O; Hatzi E; Papassotiriou I; Hatzis T Nutrition; 2005; 21(7-8):799-807. PubMed ID: 15975487 [TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal Tolerance and Protein Absorption Markers with a New Peptide Enteral Formula Compared to a Standard Intact Protein Enteral Formula in Critically Ill Patients. de Brito-Ashurst I; Klebach M; Tsompanaki E; Kaul S; van Horssen P; Hofman Z Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371872 [TBL] [Abstract][Full Text] [Related]
27. Characteristics of enteral and oral nutrition support among infants and young children in the pediatric intensive care unit: A descriptive cohort study. Winderlich J; Little B; Oberender F; Bollard T; Farrell T; Jenkins S; Landorf E; McCall A; Menzies J; O'Brien K; Rowe C; Sim K; van der Wilk M; Woodgate J; Paul E; Udy AA; Ridley EJ JPEN J Parenter Enteral Nutr; 2024 Oct; 48(7):803-809. PubMed ID: 39037417 [TBL] [Abstract][Full Text] [Related]
28. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Mesejo A; Acosta JA; Ortega C; Vila J; Fernández M; Ferreres J; Sanchis JC; López F Clin Nutr; 2003 Jun; 22(3):295-305. PubMed ID: 12765670 [TBL] [Abstract][Full Text] [Related]
29. Daily protein and energy intakes of infants fed a commercial infant formula with a reduced protein concentration of 2.2 g/100 kcal: an impact of feeding interval on energy intake. Jinno S; Yamazaki K; Nakamura Y; Kinouchi T Biosci Biotechnol Biochem; 2020 Jun; 84(6):1259-1264. PubMed ID: 31996104 [TBL] [Abstract][Full Text] [Related]
30. Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months. Räihä NC; Fazzolari-Nesci A; Cajozzo C; Puccio G; Monestier A; Moro G; Minoli I; Haschke-Becher E; Bachmann C; Van't Hof M; Carrié Fässler AL; Haschke F J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):275-81. PubMed ID: 12352513 [TBL] [Abstract][Full Text] [Related]
31. 24-Hour protein, arginine and citrulline metabolism in fed critically ill children - A stable isotope tracer study. de Betue CTI; Garcia Casal XC; van Waardenburg DA; Schexnayder SM; Joosten KFM; Deutz NEP; Engelen MPKJ Clin Nutr; 2017 Jun; 36(3):876-887. PubMed ID: 28089618 [TBL] [Abstract][Full Text] [Related]
32. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. Kouwenhoven SMP; Antl N; Finken MJJ; Twisk JWR; van der Beek EM; Abrahamse-Berkeveld M; van de Heijning BJM; Schierbeek H; Holdt LM; van Goudoever JB; Koletzko BV Am J Clin Nutr; 2020 May; 111(5):962-974. PubMed ID: 31868201 [TBL] [Abstract][Full Text] [Related]
33. Association between protocol change to a higher-protein formula with lower energy targets and nutrient delivery in critically ill patients with COVID-19: A retrospective cohort study. Wittholz K; Hinckfus C; Karahalios A; Panganiban H; Phillips N; Rotherham H; Rechnitzer T; Ali Abdelhamid Y; Deane AM; Fetterplace K JPEN J Parenter Enteral Nutr; 2024 May; 48(4):429-439. PubMed ID: 38477349 [TBL] [Abstract][Full Text] [Related]
34. Use of standard enteral formula versus enteric formula with prebiotic content in nutrition therapy: A randomized controlled study among neuro-critical care patients. Tuncay P; Arpaci F; Doganay M; Erdem D; Sahna A; Ergun H; Atabey D Clin Nutr ESPEN; 2018 Jun; 25():26-36. PubMed ID: 29779815 [TBL] [Abstract][Full Text] [Related]
35. Nutrient-enriched formula versus standard formula for preterm infants. Walsh V; Brown JVE; Askie LM; Embleton ND; McGuire W Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004204. PubMed ID: 31314903 [TBL] [Abstract][Full Text] [Related]
36. Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation. Cunningham S; Rodriguez A; Boyd KA; McIntosh E; Lewis SC; Health Technol Assess; 2015 Sep; 19(71):i-xxiii, 1-172. PubMed ID: 26364905 [TBL] [Abstract][Full Text] [Related]
37. A supplemental intravenous amino acid infusion sustains a positive protein balance for 24 hours in critically ill patients. Sundström Rehal M; Liebau F; Tjäder I; Norberg Å; Rooyackers O; Wernerman J Crit Care; 2017 Dec; 21(1):298. PubMed ID: 29212550 [TBL] [Abstract][Full Text] [Related]
38. Early-Life Metabolic and Hormonal Markers in Blood and Growth until Age 2 Years: Results from a Randomized Controlled Trial in Healthy Infants Fed a Modified Low-Protein Infant Formula. Kouwenhoven SMP; Fleddermann M; Finken MJJ; Twisk JWR; van der Beek EM; Abrahamse-Berkeveld M; van de Heijning BJM; van Harskamp D; van Goudoever JB; Koletzko BV Nutrients; 2021 Apr; 13(4):. PubMed ID: 33915788 [TBL] [Abstract][Full Text] [Related]
39. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. Brunton JA; Saigal S; Atkinson SA J Pediatr; 1998 Sep; 133(3):340-5. PubMed ID: 9738713 [TBL] [Abstract][Full Text] [Related]
40. Dilute versus full strength formula in exclusively formula-fed preterm or low birth weight infants. Basuki F; Hadiati DR; Turner T; McDonald S; Hakimi M Cochrane Database Syst Rev; 2013 Nov; (11):CD007263. PubMed ID: 24194466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]